HALIFAX, NS / ACCESS Newswire / January 23, 2026 / Silver Tiger Metals Inc. (TSXV:SLVR) and (OTCQX:SLVTF) ("Silver Tiger" or ...
Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
HALIFAX, NS / ACCESS Newswire / January 23, 2026 / Silver Tiger Metals Inc. (TSXV:SLVR) and (OTCQX:SLVTF) ("Silver Tiger" or the "Corporation") is pleased to announce the filing of a Preliminary Econo ...
After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...
The Punch on MSN
Fire guts petrol station, church in Oyo
An explosion has rocked a Rain Oil Filling Station on the Ogbomoso/Ilorin Old Road in Ogbomoso North Local Government Area of ...
Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including ...
VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ - Thesis Gold Inc. ("Thesis" or the "Company") (TSXV: TAU) (WKN: A3EP87) (OTCQX: THSGF) is pleased to announce the filing ...
Thesis Gold Files Pre-Feasibility Technical Report For The Lawyers-Ranch Gold-Silver Project. VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ - Thesis Gold Inc. ( Thesis or the Company ) (TSXV: TAU) (WKN: ...
Corcept recently suffered a blow after relacorilant was rejected by the FDA for use in Cushing’s syndrome.
Detailed price information for Namibia Critical Metals Inc (NMI-X) from The Globe and Mail including charting and trades.
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results